Atlas Trials

The Effect of Rifampicin on the Pharmacokinetics of Intracellular Tenofovir-diphosphate and Tenofovir When Coadministered With Tenofovir Alafenamide Fumarate During the Maintenance Phase of Tuberculosis Treatment in TB/HIV-1 Coinfected Participants

Clinical trial NCT04424264 · COMPLETED

Trial details

NCT number
NCT04424264
Sponsor
Professor Francois Venter
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV-1-infectionTuberculosis
Start date
2019-12-05
Primary completion
2020-10-30
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.